Disease model: hyperinsulinemia and insulin resistance. Part A-targeted disruption of insulin signaling or glucose transport (Q34293106)

1 August 2017

1 reference

title

Disease model: hyperinsulinemia and insulin resistance. Part A-targeted disruption of insulin signaling or glucose transport (English)

1 reference

1 August 2017

1 reference

1 reference

Sone H

1

1 reference

1 August 2017

Suzuki H

series ordinal

2

1 reference

1 August 2017

Takahashi A

series ordinal

3

1 reference

1 August 2017

Yamada N

series ordinal

4

1 reference

1 August 2017

1 July 2001

1 reference

Trends in Molecular Medicine

1 August 2017

1 reference

1 August 2017

7

1 reference

1 August 2017

7

1 reference

1 August 2017

320-322

1 reference

Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Early neonatal death in mice homozygous for a null allele of the insulin receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

The IRS-signalling system: a network of docking proteins that mediate insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Disruption of IRS-2 causes type 2 diabetes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Insulin receptor substrate-2 is not necessary for insulin- and exercise-stimulated glucose transport in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Insulin receptor substrate 3 is not essential for growth or glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Muscle-specific transgenic complementation of GLUT4-deficient mice. Effects on glucose but not lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2902041-X

7 January 2021

10.1016/S1471-4914(01)02041-X

Identifiers

DOI

1 reference

1 August 2017

1 reference